References
- Genotropin prescribing informationNew York, NYPfizer Inc2011 Available at: http://www.genotropin.com/misc/prescribing-information.aspxAccessed on June 2, 2013
- FinkelsteinBSImperialeTFSperoffTMarreroURadcliffeDJCuttlerLEffect of growth hormone therapy on height in children with idiopathic short stature: a meta-analysisArch Pediatr Adolesc Med200215623024011876666
- DumasHPanayiotopoulosPParkerDPongpairoichanaVUnderstanding and meeting the needs of those using growth hormone injection devicesBMC Endocr Disord20066517034628
- Hey-HadaviJPleilADeebLCEase of use and preference for a new disposable self-injection pen compared with a reusable pen for administering recombinant human growth hormone: A multicenter, 2-month, single-arm, open-label clinical trial in patient-caregiver dyadsClin Ther2010322036204721118739
- PleilAMKimelMMcCormackJRajicicNHey-HadaviJPsychometric assessment of the Injection Pen Assessment Questionnaire (IPAQ): measuring ease of use and preference with injection pens for human growth hormoneHealth Qual Life Outcomes20121012623046797
- WildDGroveAMartinMISPOR Task Force for Translation and Cultural AdaptationPrinciples of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR Task Force for Translation and Cultural AdaptationValue Health200589410415804318
- PleilAKimelMWollmannHThe adaptation of the Injection Pen Assessment Questionnaire for use in Europe – validation results from a large multicenter study of recombinant human growth hormone treatment naïve children and adults, November 2012 (poster presentation)ISPOR 15th Annual European CongressBerlin, Germany
- HodgesJLLehmannELEstimates of location based on rank testsAnn Math Statist196334598611
- AgrestiACategorical Data AnalysisHoboken, NJWiley2002
- SennSCross-Over Trials in Clinical Research2nd edHoboken, NJWiley2002
- FidottiEA history of growth hormone injection devicesJ Pediatr Endocrinol Metab20011449750111393569
- MüllerJSkakkebækNEJacobsenBBNorditropin® SimpleXx™: a liquid human growth hormone formulation, a pen system and an auto-insertion deviceHorm Res199951Suppl 310911210592453
- RapaportRSaengerPSchmidtHValidation and ease of use of a new pen device for self-administration of recombinant human growth hormone: results from a two-center usability studyMed Devices (Auckl)2013614114624039458
- SjöblomKAlbertsson-WiklandKBengtssonBAPatient evaluation of a new injection pen for growth hormone treatment in children and adultsActa Paediatr Suppl199541163658563072
- DorrHGZabranskySKellerEAre needle-free injections a useful alternative for growth hormone therapy in children? Safety and pharmacokinetics of growth hormone delivered by a new needle-free injection device compared to a fine gauge needleJ Pediatr Endocrinol Metab20031638339212705363
- KappelgaardAMMikkelsenSKnudsenTKFuchsGSPatient preference for a new growth hormone injection device: results of an open-label study in Japanese pediatric patientsJ Pediatr Endocrinol Metab2011247–848949621932587
- FuchsGSMikkelsenSKnudsenTKKappelgaardAMEase of use and acceptability of a new pen device for the administration of growth hormone therapy in pediatric patients: an open-label, uncontrolled usability testClin Ther200931122906291420110030
- TauberMJaquetDJesuran-PerelroizenMPetrusMBertrandACoutantRUser assessment of Norditropin NordiFlex®, a new prefilled growth hormone pen: a Phase IV multicenter prospective studyPatient Prefer Adherence2013745546223737664